124 related articles for article (PubMed ID: 3930642)
1. Synthesis and stereochemical determination of diunsaturated valproic acid analogs including its major diunsaturated metabolite.
Acheampong A; Abbott FS
J Lipid Res; 1985 Aug; 26(8):1002-8. PubMed ID: 3930642
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective synthesis of the diunsaturated metabolites of valproic acid.
Lee RD; Kassahun K; Abbott FS
J Pharm Sci; 1989 Aug; 78(8):667-71. PubMed ID: 2506329
[TBL] [Abstract][Full Text] [Related]
3. Identification of valproic acid metabolites in human serum and urine using hexadeuterated valproic acid and gas chromatographic mass spectrometric analysis.
Acheampong A; Abbott F; Burton R
Biomed Mass Spectrom; 1983 Nov; 10(11):586-95. PubMed ID: 6419788
[TBL] [Abstract][Full Text] [Related]
4. Ion trap detector--capillary gas chromatography of valproic acid and its mono-unsaturated metabolites in serum using methyl ester derivatives.
Gaetani E; Laureri CF; Vitto M
J Pharm Biomed Anal; 1992; 10(2-3):193-7. PubMed ID: 1391099
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Baillie TA
Drug Metab Dispos; 1986; 14(4):454-64. PubMed ID: 2873993
[TBL] [Abstract][Full Text] [Related]
6. Five doubly unsaturated metabolites of valproic acid in urine and plasma of patients on valproic acid therapy.
Kochen W; Sprunck HP; Tauscher W; Klemens M
J Clin Chem Clin Biochem; 1984 Apr; 22(4):309-17. PubMed ID: 6429268
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Lockard JS; Thummel KE; Baillie TA
Drug Metab Dispos; 1986; 14(4):443-53. PubMed ID: 2873992
[TBL] [Abstract][Full Text] [Related]
8. In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.
Kassahun K; Abbott F
Drug Metab Dispos; 1993; 21(6):1098-106. PubMed ID: 7905390
[TBL] [Abstract][Full Text] [Related]
9. The hydroxamate of valproic acid, a compound produced by oximation of urine from patients under valproic therapy.
Libert R; Van Hoof F; Schanck A; Hoffmann E
Biomed Environ Mass Spectrom; 1986 Nov; 13(11):599-603. PubMed ID: 2948586
[TBL] [Abstract][Full Text] [Related]
10. Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity.
Fisher E; Siemes H; Pund R; Wittfoht W; Nau H
Epilepsia; 1992; 33(1):165-71. PubMed ID: 1733752
[TBL] [Abstract][Full Text] [Related]
11. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
Rettenmeier AW; Prickett KS; Gordon WP; Bjorge SM; Chang SL; Levy RH; Baillie TA
Drug Metab Dispos; 1985; 13(1):81-96. PubMed ID: 2858383
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry.
Fisher E; Wittfoht W; Nau H
Biomed Chromatogr; 1992; 6(1):24-9. PubMed ID: 1600371
[TBL] [Abstract][Full Text] [Related]
13. Capillary gas chromatography-mass spectrometry of valproic acid metabolites in serum and urine using tert.-butyldimethylsilyl derivatives.
Abbott FS; Kassam J; Acheampong A; Ferguson S; Panesar S; Burton R; Farrell K; Orr J
J Chromatogr; 1986 Mar; 375(2):285-98. PubMed ID: 3084529
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
Kassahun K; Farrell K; Abbott F
Drug Metab Dispos; 1991; 19(2):525-35. PubMed ID: 1676665
[TBL] [Abstract][Full Text] [Related]
15. Conjugated alpha-linolenic acid isomers in bovine milk and muscle.
Plourde M; Destaillats F; Chouinard PY; Angers P
J Dairy Sci; 2007 Nov; 90(11):5269-75. PubMed ID: 17954767
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling of valproic acid by cDNA-expressed human cytochrome P450 enzymes using negative-ion chemical ionization gas chromatography-mass spectrometry.
Anari MR; Burton RW; Gopaul S; Abbott FS
J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):217-27. PubMed ID: 10901126
[TBL] [Abstract][Full Text] [Related]
17. Methods for analysis of conjugated linoleic acids and trans-18:1 isomers in dairy fats by using a combination of gas chromatography, silver-ion thin-layer chromatography/gas chromatography, and silver-ion liquid chromatography.
Cruz-Hernandez C; Deng Z; Zhou J; Hill AR; Yurawecz MP; Delmonte P; Mossoba MM; Dugan ME; Kramer JK
J AOAC Int; 2004; 87(2):545-62. PubMed ID: 15164853
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and chemical structure of nonmethylene-interrupted dienoic fatty acids in American oyster Crassostrea virginica.
Paradis M; Ackman RG
Lipids; 1975 Jan; 10(1):12-6. PubMed ID: 1123972
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of medium-chain fatty acid beta-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid.
Bjorge SM; Baillie TA
Biochem Biophys Res Commun; 1985 Oct; 132(1):245-52. PubMed ID: 3933498
[TBL] [Abstract][Full Text] [Related]
20. Determination of valproic acid and its metabolites by gas chromatography-mass spectrometry with selected ion monitoring.
Tatsuhara T; Muro H; Matsuda Y; Imai Y
J Chromatogr; 1987 Jul; 399():183-95. PubMed ID: 3116023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
